These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6339399)

  • 41. A basal-defined medium for the study of proteolytic activity of Serratia marcescens.
    Bromke BJ; Venuti E
    Can J Microbiol; 1999 Jan; 45(1):88-91. PubMed ID: 10349724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico characterization of broad range proteases produced by Serratia marcescens EGD-HP20.
    Fuke P; Pal RR; Khardenavis AA; Purohit HJ
    J Basic Microbiol; 2018 Jun; 58(6):492-500. PubMed ID: 29566274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolutionary operation (EVOP) to optimize whey independent serratiopeptidase production from Serratia marcescens NRRL B-23112.
    Pansuriya RC; Singhal RS
    J Microbiol Biotechnol; 2010 May; 20(5):950-7. PubMed ID: 20519921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of humoral and cell-mediated immunity in resistance to systemic Serratia infection.
    Kumagai Y; Okada K; Sawae Y
    J Med Microbiol; 1992 Apr; 36(4):245-9. PubMed ID: 1560446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic analysis of extracellular proteins of Serratia marcescens.
    Hines DA; Saurugger PN; Ihler GM; Benedik MJ
    J Bacteriol; 1988 Sep; 170(9):4141-6. PubMed ID: 2842305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease.
    Oda T; Kojima Y; Akaike T; Ijiri S; Molla A; Maeda H
    Infect Immun; 1990 May; 58(5):1269-72. PubMed ID: 1691142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathologic patterns of Serratia marcescens pneumonia.
    Goldstein JD; Godleski JJ; Balikian JP; Herman PG
    Hum Pathol; 1982 May; 13(5):479-84. PubMed ID: 7042532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and Characterization of Serratiopeptidase Producing Bacteria from Mulberry Phyllosphere.
    Koul D; Chander D; Manhas RS; Chaubey A
    Curr Microbiol; 2021 Jan; 78(1):351-357. PubMed ID: 33179157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of bacterial proteases in pseudomonal and serratial keratitis.
    Matsumoto K
    Biol Chem; 2004 Nov; 385(11):1007-16. PubMed ID: 15576320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Purification and characterization of two proteases from a clinical isolate of Serratia marcescens].
    Matsumoto K; Kamata R
    Nippon Ganka Gakkai Zasshi; 1982; 86(8):833-8. PubMed ID: 6758555
    [No Abstract]   [Full Text] [Related]  

  • 51. SlpE is a calcium-dependent cytotoxic metalloprotease associated with clinical isolates of Serratia marcescens.
    Stella NA; Callaghan JD; Zhang L; Brothers KM; Kowalski RP; Huang JJ; Thibodeau PH; Shanks RMQ
    Res Microbiol; 2017; 168(6):567-574. PubMed ID: 28366837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Listeria monocytogenes and Serratia marcescens infections as models for Th1/Th2 immunity in laboratory cats.
    Pedersen NC; Dean GA; Bernales J; Sukura A; Higgins J
    Vet Immunol Immunopathol; 1998 May; 63(1-2):83-103. PubMed ID: 9656444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958.
    Matsumoto K; Maeda H; Takata K; Kamata R; Okamura R
    J Bacteriol; 1984 Jan; 157(1):225-32. PubMed ID: 6418718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific and Nonspecific immunity to Serratia marcescens infection.
    Simberkoff MS; Moldover NH; Rahal JJ
    J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice.
    Akaike T; Molla A; Ando M; Araki S; Maeda H
    J Virol; 1989 May; 63(5):2252-9. PubMed ID: 2522998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies of lipase and antilipase on different strains of the genera Serratia, Aeromonas and Vibrio (author's transl)].
    Caselitz FH; Freitag V; Meyer HJ
    Zentralbl Bakteriol A; 1980 Mar; 246(3):336-43. PubMed ID: 6999789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of two Serratia marcescens proteases.
    Doerr M; Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):6-19. PubMed ID: 6380155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Free proteolytic activity of Serratia marcescens. I. Inductive capacity of several protein substrates].
    Hernández-Delgadillo R; Ruiz-Cruz JJ; Trujillo-Chagoya FJ; Patiño-Hernández LD
    Rev Latinoam Microbiol; 1988; 30(4):363-8. PubMed ID: 3072633
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulmonary clearance of Haemophilus pleuropneumoniae and Serratia marcescens in mice.
    Sebunya TN; Saunders JR
    Am J Vet Res; 1982 Oct; 43(10):1799-801. PubMed ID: 6756225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparative study of deoxyribonuclease activity in pigmented strains of Serratia marcescens and their pigmentless variants].
    Gareĭshina AZ; Iusupova DV; Beliaeva MI
    Mikrobiologiia; 1970; 39(6):1034-9. PubMed ID: 4935075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.